Immuneering (IMRX) Asset Utilization Ratio (2021 - 2023)

Immuneering (IMRX) recorded quarterly Asset Utilization Ratio of 0.0 in Q3 2023, down 98.86% quarter-over-quarter from 0.0 in Q2 2023, and down 99.9% on a YoY basis from 0.0 in Q3 2022.

Immuneering (IMRX) Asset Utilization Ratio (2021 - 2023) Analysis & Trends

Immuneering's Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q3 2023.

  • In Q3 2023, Asset Utilization Ratio fell 99.9% year-over-year to 0.0; the TTM figure through Sep 2023 stood at 0.0 (down 99.9% YoY), while the FY2022 annual figure was 0.0, down 89.19% from the prior year.
  • Asset Utilization Ratio was 0.0 for Q3 2023 at Immuneering, down from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q3 2021 to a low of 0.0 in Q3 2023.
  • Historically, Asset Utilization Ratio has averaged 0.01 across 3 years, with a median of 0.0 in 2022.
  • The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio plunged 80.32% in 2022, then slumped 99.9% in 2023.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then slumped by 80.32% to 0.0 in 2022, then slumped by 99.85% to 0.0 in 2023.
  • The last three Asset Utilization Ratio figures came in at 0.0 (Q3 2023), 0.0 (Q2 2023), and 0.0 (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 0.55
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.60
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 1,422.00
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 0.47
9 Abivax 91.71 Bn 91.71 Bn - -
10 Immuneering 255.40 Mn 255.40 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.02